What if you invested $1000 in BDX on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Becton, Dickinson and Company has delivered an average annual return of 8.8%. The stock peaked in 2013 with a massive +42.0% gain, while investors faced a downturn in 2008 (-20.0%). Overall, the stock finished in the green 14 times out of 20 years.
Avg Return
+8.8%
Win Rate
70%
14W - 6L
Best
+42.0%
2013
Worst
-20.0%
2008
Performance Consistency
About Becton, Dickinson and Company
Visit Website ↗BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories.
Key Business Segments
BD Medical
Produces a broad array of medical devices, including medication delivery systems, diabetes care solutions, and other medical supplies.
BD Life Sciences
Provides products for the collection and transport of diagnostic specimens, instruments and reagents for the diagnosis of infectious diseases, and flow cytometry systems for research and clinical applications.
BD Interventional
Offers solutions for vascular, urology, oncology, and surgical specialty products.
Key Innovations
- ✓Pioneered the development of standardized, sterile medical devices, such as syringes and thermometers.
- ✓Introduced the 'Transfuso-Vac' blood collection system, which revolutionized blood banking.
- ✓Developed the Luer-Lok syringe tip, a secure method for attaching and detaching needles.
Historical Milestones
Becton, Dickinson and Company is founded.
Introduces the 'Transfuso-Vac' blood collection system.
Acquires CareFusion, a medical technology company specializing in medication management and patient safety.
Acquires C.R. Bard, significantly expanding its portfolio of medical technologies.